Corpus Intelligence IC Memo — COTEAU DES PRAIRIES 2026-04-26 12:47 UTC
IC Memo — COTEAU DES PRAIRIES
Investment Committee Memorandum | SD | 25 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COTEAU DES PRAIRIES

CCN 431339 | ROBERTS, SD | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

COTEAU DES PRAIRIES is a 25-bed rural/critical access in ROBERTS, SD with $20.7M in net patient revenue and a -3.1% operating margin. The hospital serves a payer mix of 52.5% Medicare, 18.1% Medicaid, and 29.4% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.1% to 4.3% (+736bps).

Net Revenue HCRIS$20.7M
Current EBITDA COMPUTED$-638K
Operating Margin COMPUTED-3.1%
Occupancy HCRIS16.0%
Revenue / Bed COMPUTED$826K
Net-to-Gross HCRIS51.1%
Distress Probability ML62.9%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
42
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -3.1% places it above the state median. Among 42 size-comparable peers (12-50 beds), the median margin is -1.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COTEAU DES PRAIRIES (Target)SD25$20.7M-3.1%
AVERA ST. LUKESSD50$210.6M-7.3%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
SIOUXLAND SURGERY CENTERSD38$105.7M40.1%
AVERA ST MARYSSD50$105.0M-10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$434K+210bp18mo
Cost to Collect4.5%2.5%$413K+200bp12mo
Denial Rate Reduction12.0%6.5%$409K+198bp12mo
A/R Days Reduction5200.0%3800.0%$251K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$434K
Cost to Collect
$413K
Denial Rate Reduction
$409K
A/R Days Reduction
$251K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-638K
+ RCM Uplift+$1.5M
Pro Forma EBITDA$883K
Current Margin-3.1%
Pro Forma Margin4.3%
WC Released (1x)$792K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-981K$11.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-981K$11.8M0.00x-100.0%
Bull Case9.0x11.0x$-883K$16.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-883K$17.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$3.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$3.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 16.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 62.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 12-50 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-9.2% / P50=-1.8% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.